Sara Bahadoram
-
- Renal cell carcinoma treatment 2
- Blood properties and coagulation 1
-
- Renal and related cancers 2
-
- Systemic Lupus Erythematosus Research 2
-
- Inflammatory Biomarkers in Disease Prognosis 2
-
- Hemoglobinopathies and Related Disorders 2
-
- ECG Monitoring and Analysis 1
-
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Mohammad BahadoramShakiba HassanzadehMohammad DavoodiMaedeh BarahmanLadan MafakherAli GhorbaniMehrdad Dargahi-MalamirElham Rajaei
- Journals
- Journal of Oncology Pharmacy Practice (1 paper)DARU Journal of Pharmaceutical Sciences (1 paper)Journal of Renal Injury Prevention (2 papers)
- Partner nations
- IranNetherlandsUnited States
In The Last Decade
Sara Bahadoram
13 papers receiving 297 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Pulmonary and Respiratory Medicine 120
- Cancer Research 53
- Molecular Biology 141
- Nutrition and Dietetics 27
- Rheumatology 23
Countries citing papers authored by Sara Bahadoram
This map shows the geographic impact of Sara Bahadoram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Bahadoram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Bahadoram more than expected).
Fields of papers citing papers by Sara Bahadoram
This network shows the impact of papers produced by Sara Bahadoram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Bahadoram. The network helps show where Sara Bahadoram may publish in the future.
Co-authorship network
The 19 scholars most cited alongside Sara Bahadoram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2022 | 1 | |
| 3 | Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.breakdown → | 2022 | 202 |
| 4 | 2022 | 5 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 1 | |
| 7 | An update on the mechanism and therapeutic implications of, pregnancy and lactation-associated osteoporosis; a narrative review | 2020 | 1 |
| 8 | 2020 | 2 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 4 | |
| 11 | 2017 | 0 | |
| 12 | 2016 | 0 | |
| 13 | 2015 | 60 | |
| 14 | QT Dispersion: Does It Change after Percutaneous Coronary Intervention? | 2011 | 8 |
| 15 | ANTISPASMODIC EFFECT OF TECOMA STANS (L.) JUSS LEAF EXTRACT ON RAT ILEUM | 2007 | 16 |
About Sara Bahadoram
Sara Bahadoram is a scholar working on Transplantation, Otorhinolaryngology and Genetics, having authored 15 papers that have together received 309 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (2 papers), Renal and related cancers (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), Systemic Lupus Erythematosus Research (2 papers), Hemoglobinopathies and Related Disorders (2 papers), ECG Monitoring and Analysis (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper) and Blood properties and coagulation (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (120 citations), Cancer Research (53 citations) and Molecular Biology (141 citations). Sara Bahadoram has collaborated with scholars based in Iran, Netherlands and United States. Frequent co-authors include Mohammad Bahadoram, Shakiba Hassanzadeh, Mohammad Davoodi, Maedeh Barahman, Ladan Mafakher, Ali Ghorbani, Mehrdad Dargahi-Malamir, Elham Rajaei, Karim Mowla and Mohammad Kazem Gharib Naseri. Their work appears in journals such as Journal of Oncology Pharmacy Practice, DARU Journal of Pharmaceutical Sciences, Journal of Renal Injury Prevention, SHILAP Revista de lepidopterología and Future Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.